Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

HAIFA, Israel, July 23 (Korea Bizwire) — Researchers at Israel’s Rabin Medical Center (comprised of Beilinson and Hasharon Hospitals) in collaboration with MeMed, have published prospective data on the potential utility of the analysis of IP-10, a host immune biomarker, in managing the care and treatment of patients with severe COVID-19 infection.  Initial data from the prospective study shows that continuous and rapid measurements of IP-10, a biomarker associated with inflammatory disease including infectious diseases and immune dysfunction, can [...]